Both in Diagnostics
Celldex Therapeutics vs Neogen
Over the past year CLDX returned +20.8% and NEOG returned +127.7%; their daily moves had a correlation of 0.07.
CLDX +20.8% NEOG +127.7%Growth of $1, one year, split-adjusted
| Metric | CLDX | NEOG |
|---|---|---|
| Price | $31.64 | $12.73 |
| Market cap | $2.48B | $2.78B |
| Today | +0.48% | −7.22% |
| 1 month | −19.1% | +9.2% |
| 6 months | +7.3% | +42.9% |
| Year to date | +16.5% | +82.1% |
| 1 year | +21.0% | +124.5% |
| Revenue growth (YoY) | −97.0% | −0.1% |
| Gross margin | 100.0% | 47.8% |
| Net margin | −334104.5% | −5.0% |
| P/E (TTM) | — | — |
| Price / sales | 15,725.8× | 3.2× |
| Net cash | $717.6M | -$619.2M |
| Dividend yield | — | — |
| Volatility (60d) | 47.6% | 54.8% |
| Short % of float | 12.1% | 5.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).